ESR2 and cancer: Although an oncogenic function of ERβ in the lung should not be excluded and may be associated with the biology of the tissue, the pro-invasive effects in cancer cells following upregulation of the receptor need to be considered with extra caution and further validated to exclude non-physiological activation by the artificial expression.